Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript May 14, 2025Journey Medical Corporation beats earnings expectations.
Posts Tagged ‘NASDAQ:DERM’
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
10 Cheap Hot Stocks to Buy Right Now
Periods of high market volatility can make cheap stocks attractive because sharp price swings may undervalue fundamentally strong growth companies in the short run.
Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript March 26, 2025Journey Medical Corporation beats earnings expectations.
Journey Medical Corporation (DERM): A Bull Case Theory
We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM.
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the same can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Journey Medical Corporation (NASDAQ:DERM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon.
Journey Medical Corporation (NASDAQ:DERM) Q2 2023 Earnings Call Transcript
Operator: Ladies and Gentleman, thank you for standing by.
Journey Medical Corporation (NASDAQ:DERM) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Journey Medical Corporation (NASDAQ:DERM) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Here’s What Hedge Funds Think About Dermira Inc (DERM)
Is Dermira Inc (NASDAQ:DERM) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Do Hedge Funds Love Dermira Inc (DERM)?
Like everyone else, elite investors make mistakes.
Market Movers Today: Dermira Inc (DERM), Intrepid Potash, Inc. (IPI), XL Group Ltd (XL), Sparton Corporation (SPA), and More
In a major surprise for Dermira Inc. and Wall Street alike, Dermira’s acne drug failed to meet the co-primary endpoints of two important, late-stage clinical trials.
Should You Buy Dermira Inc (DERM)?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous ...
Dermira Inc (DERM): Are Hedge Funds Right About This Stock?
After several tireless days, we have finished crunching the numbers from more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at ...
